Cross Country Healthcare, Inc.
CCRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,344,004 | $2,019,728 | $2,803,381 | $1,676,652 |
| % Growth | -33.5% | -28% | 67.2% | – |
| Cost of Goods Sold | $1,069,752 | $1,569,318 | $2,178,923 | $1,301,653 |
| Gross Profit | $274,252 | $450,410 | $624,458 | $374,999 |
| % Margin | 20.4% | 22.3% | 22.3% | 22.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $246,309 | $303,453 | $0 | $210,543 |
| SG&A Expenses | $254,809 | $314,953 | $324,209 | $220,043 |
| Sales & Mktg Exp. | $8,500 | $11,500 | $0 | $9,500 |
| Other Operating Expenses | $36,308 | $22,744 | $30,369 | $15,652 |
| Operating Expenses | $291,117 | $337,697 | $354,578 | $235,695 |
| Operating Income | -$16,865 | $112,713 | $269,880 | $139,304 |
| % Margin | -1.3% | 5.6% | 9.6% | 8.3% |
| Other Income/Exp. Net | $467 | -$9,819 | -$16,783 | -$6,096 |
| Pre-Tax Income | -$16,398 | $102,894 | $253,097 | $133,208 |
| Tax Expense | -$1,842 | $30,263 | $67,115 | $1,206 |
| Net Income | -$14,556 | $72,631 | $185,982 | $132,002 |
| % Margin | -1.1% | 3.6% | 6.6% | 7.9% |
| EPS | -0.44 | 2.07 | 5.09 | 3.6 |
| % Growth | -121.3% | -59.3% | 41.4% | – |
| EPS Diluted | -0.44 | 2.05 | 5.02 | 3.53 |
| Weighted Avg Shares Out | 33,379 | 35,158 | 37,012 | 36,689 |
| Weighted Avg Shares Out Dil | 33,379 | 35,476 | 37,536 | 37,392 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,050 | $0 | $10 | $0 |
| Interest Expense | $2,188 | $8,094 | $14,391 | $6,866 |
| Depreciation & Amortization | $17,500 | $18,347 | $12,576 | $9,452 |
| EBITDA | $16,775 | $129,335 | $280,064 | $154,556 |
| % Margin | 1.2% | 6.4% | 10% | 9.2% |